Nonlinear Association Between the Liver Fat Content and the Risk of Hyperuricemia in Prediabetic Individuals: Evidence from Cross-Sectional Health Screening Data in China.

IF 2.8 3区 医学 Q3 ENDOCRINOLOGY & METABOLISM
Ao Liu, Xin Li, Xueyi Zhang, Keke Chen, Zhi Zou, Yongbing Sun, Jing Zhou, Zhonglin Li, Xiaoling Wu, Xue Lv, Hao Li, Zhiping Guo, Yongli Li
{"title":"Nonlinear Association Between the Liver Fat Content and the Risk of Hyperuricemia in Prediabetic Individuals: Evidence from Cross-Sectional Health Screening Data in China.","authors":"Ao Liu, Xin Li, Xueyi Zhang, Keke Chen, Zhi Zou, Yongbing Sun, Jing Zhou, Zhonglin Li, Xiaoling Wu, Xue Lv, Hao Li, Zhiping Guo, Yongli Li","doi":"10.2147/DMSO.S506893","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>The impact of hepatic lipid accumulation on hyperuricemia presents an intriguing research avenue, particularly in light of existing studies linking obesity with hyperuricemia. Nevertheless, there remains a scarcity of quantitative investigations into the correlation between liver fat content (LFC) and hyperuricemia among prediabetic cohorts, notably within the Chinese demographic.</p><p><strong>Patients and methods: </strong>This cross-sectional study was conducted at the Health Management Center of Henan Provincial People's Hospital between January 2019 and December 2023, involving 2,950 pre-diabetic participants. Participants were categorized into groups based on diagnostic criteria for hyperuricemia. LFC was assessed using computed tomography. Statistical analyses included multivariate logistic regression, limited cubic spline regression models, and subgroup analyses to explore the association between LFC and hyperuricemia among individuals with pre-diabetes.</p><p><strong>Results: </strong>The prevalence of hyperuricemia among the 2,950 prediabetic individuals was observed to be 22.20%. Prediabetic individuals with hyperuricemia exhibited higher levels of LFC compared to those without hyperuricemia. This association persisted even after adjusting for other variables, indicating a heightened risk of hyperuricemia among prediabetic individuals with elevated LFC [Q4 vs Q1: odds ratio (OR 2.70), 95% confidence interval (CI) 1.93-3.79, <i>P</i> < 0.001; <i>P</i> <sub>for trend</sub> < 0.001]. Importantly, a nonlinear relationship between LFC and hyperuricemia risk was identified in the prediabetic individuals, showing a significant increase in hyperuricemia risk when LFC exceeded 8.4% (OR per standard deviation = 1.05, 95% CI: 1.02-1.08, <i>P</i> < 0.001).</p><p><strong>Conclusion: </strong>In individuals with prediabetes, a higher LFC is associated with an elevated risk of hyperuricemia, especially when LFC exceeds 8.4%.</p>","PeriodicalId":11116,"journal":{"name":"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy","volume":"18 ","pages":"423-434"},"PeriodicalIF":2.8000,"publicationDate":"2025-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11830934/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/DMSO.S506893","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: The impact of hepatic lipid accumulation on hyperuricemia presents an intriguing research avenue, particularly in light of existing studies linking obesity with hyperuricemia. Nevertheless, there remains a scarcity of quantitative investigations into the correlation between liver fat content (LFC) and hyperuricemia among prediabetic cohorts, notably within the Chinese demographic.

Patients and methods: This cross-sectional study was conducted at the Health Management Center of Henan Provincial People's Hospital between January 2019 and December 2023, involving 2,950 pre-diabetic participants. Participants were categorized into groups based on diagnostic criteria for hyperuricemia. LFC was assessed using computed tomography. Statistical analyses included multivariate logistic regression, limited cubic spline regression models, and subgroup analyses to explore the association between LFC and hyperuricemia among individuals with pre-diabetes.

Results: The prevalence of hyperuricemia among the 2,950 prediabetic individuals was observed to be 22.20%. Prediabetic individuals with hyperuricemia exhibited higher levels of LFC compared to those without hyperuricemia. This association persisted even after adjusting for other variables, indicating a heightened risk of hyperuricemia among prediabetic individuals with elevated LFC [Q4 vs Q1: odds ratio (OR 2.70), 95% confidence interval (CI) 1.93-3.79, P < 0.001; P for trend < 0.001]. Importantly, a nonlinear relationship between LFC and hyperuricemia risk was identified in the prediabetic individuals, showing a significant increase in hyperuricemia risk when LFC exceeded 8.4% (OR per standard deviation = 1.05, 95% CI: 1.02-1.08, P < 0.001).

Conclusion: In individuals with prediabetes, a higher LFC is associated with an elevated risk of hyperuricemia, especially when LFC exceeds 8.4%.

糖尿病前期人群肝脏脂肪含量与高尿酸血症风险之间的非线性关联:来自中国横断面健康筛查数据的证据
目的:肝脂质积累对高尿酸血症的影响提供了一个有趣的研究途径,特别是考虑到现有的研究将肥胖与高尿酸血症联系起来。然而,在糖尿病前期人群中,特别是在中国人群中,肝脏脂肪含量(LFC)与高尿酸血症之间的相关性的定量研究仍然缺乏。患者和方法:本横断面研究于2019年1月至2023年12月在河南省人民医院健康管理中心进行,涉及2,950名糖尿病前期参与者。参与者根据高尿酸血症的诊断标准进行分组。使用计算机断层扫描评估LFC。统计分析包括多元逻辑回归、有限三次样条回归模型和亚组分析,以探讨糖尿病前期个体中LFC与高尿酸血症之间的关系。结果:2950例糖尿病前期患者高尿酸血症患病率为22.20%。与没有高尿酸血症的糖尿病前期患者相比,高尿酸血症患者的LFC水平更高。即使在调整了其他变量后,这种关联仍然存在,表明LFC升高的糖尿病前期患者高尿酸血症的风险增加[Q4 vs Q1:优势比(OR 2.70), 95%置信区间(CI) 1.93-3.79, P < 0.001;P代表趋势< 0.001]。重要的是,在糖尿病前期个体中发现了LFC与高尿酸血症风险之间的非线性关系,当LFC超过8.4%时,高尿酸血症风险显著增加(每标准差OR = 1.05, 95% CI: 1.02-1.08, P < 0.001)。结论:在糖尿病前期患者中,较高的LFC与高尿酸血症的风险升高相关,特别是当LFC超过8.4%时。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Pharmacology, Toxicology and Pharmaceutics-Pharmacology
CiteScore
5.90
自引率
6.10%
发文量
431
审稿时长
16 weeks
期刊介绍: An international, peer-reviewed, open access, online journal. The journal is committed to the rapid publication of the latest laboratory and clinical findings in the fields of diabetes, metabolic syndrome and obesity research. Original research, review, case reports, hypothesis formation, expert opinion and commentaries are all considered for publication.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信